NCT05076682 2025-12-03
Renaissance
Fudan University
Phase 2 Recruiting
Clinical Trials
7 trialsNCT00003808 2023-06-22
Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00003684 2020-04-03
Theophylline in Treating Cancer Patients With Shortness of Breath
Canadian Cancer Trials Group
Phase 3 Completed
NCT02080078 2019-05-03
A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline
AHS Cancer Control Alberta
Phase 1 Terminated
NCT00175812 2015-06-24
Differentiation Induction in Acute Myelogenous Leukemia
University of Bergen
Phase 1/2 Completed
NCT01799161 2014-11-17
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
University of Miami
Phase 1 Withdrawn
NCT01017939 2013-04-12
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Completed